The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

Prosecutors say McKinsey “knew the risk and dangers” of OxyContin and knew that Purdue Pharma ... sales in 2013 after a drop in business, McKinsey consultants accompanied Purdue sales ...

Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The Commonwealth of Pennsylvania is set to receive as much as $212 million of a $7.4 billion settlement from Purdue Pharma ...

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in ...